You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Cambridge, Massachusetts-based Pyxis Oncology on Tuesday said it has raised $152 million in a Series B funding round that it will use to advance its antibody-drug conjugate (ADC) pipeline.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.